Pharma Journalist

Developments in Protein Engineering An interview with panelist: Maria Lucas, CEO, Zymvol

By Pharma Journalist on September 14, 2021

Related Posts

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal as Industry Leaders Convene at TRP Summit

IQ MPS Leaders to Share Industry Progress on Advancing In Vitro NAMs Toward Regulatory Acceptance at the Investigative & Preclinical Toxicology Summit

4th ADC Linker & Conjugation Summit Announces 2026 Agenda, Bringing Specialist Chemists Together in Boston This July

Turning Biophysical Data into Confident Drug Discovery Decisions

Targeted LNP Delivery Beyond the Liver: The Challenges & the Solution

The Toxicology Workshop Day Industry Leaders Are Prioritizing Ahead of Investigative & Preclinical Toxicology Summit 2026

In Vivo Cell Engineering Reaches an Inflection Point as the 5th In Vivo Cell Engineering & Gene Editing Summit Returns to Boston
Comments (0)
Add Comment